Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
about
Toxic epidermal necrolysis and Stevens-Johnson syndromeBiologics in dermatology: an integrated reviewSevere desquamating disorder after liver transplant: toxic epidermal necrolysis or graft versus host disease?Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactionsThe current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.Skin Detachment and Regrowth in Toxic Epidermal NecrolysisCauses and treatment outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in 82 adult patients.Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.Long-term follow-up of patients treated for toxic epidermal necrolysis.Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.Toxic epidermal necrolysis/Stevens-Johnson syndrome: current trends in management.The use of i.v. IG therapy in dermatology.Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis.Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of treatment options.Serum bicarbonate as a marker to predict mortality in toxic epidermal necrolysis.The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis.Clinical applications of immunoglobulin: update.Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies.U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.Toxic epidermal necrolysis treatment and outcomes: a retrospective analysis of 10 patients treated with intravenous immunoglobulin.Treatments for Severe Cutaneous Adverse Reactions.SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!
P2860
Q21202877-C816F1F0-F729-45A8-9BDF-6B411A0F1B70Q27004638-9E827CCD-1E4D-45A8-ACE0-5FB8DD681A0BQ28200201-1648779D-E34E-4B87-9F69-2888047A0D0FQ28395744-76D02FE9-B31A-4EF5-B564-1F9D3A8F066DQ34225850-DF60652F-D845-4B6B-8BEF-17002BD18CE9Q34416041-1A08ED38-E538-420A-84DF-799A3144271EQ36025252-028EFAD1-9D39-4563-A7A1-4E0D08FB6E00Q36318645-414518C5-72FE-43B2-A38C-EE39811530E6Q36432661-4606FCF1-FE44-4C67-81F9-6DD0AE9D0F07Q36711702-DCF4CF87-4B0A-45B6-A34E-E2C42D46EA03Q36884071-9654B245-5E82-4D0E-8D05-78E9B0B58DE4Q36986054-634EDFA0-829E-4BF2-97E3-45F7558E76EBQ37053492-96405D39-3E3C-4F35-B738-D7144F33308EQ37802203-8EEF08EC-DAD5-4A21-8F0D-7BEAC22BFD66Q37853599-381F2D54-7884-4227-8138-67EFBB30A80FQ37925705-D05C3DFB-E89B-47CC-814E-C7C8E936D451Q37998131-6042F8E4-9EEF-48EE-8932-AE8123ECE30FQ38050751-1DB79B53-E232-4E70-A3A2-E1A62B94C6F4Q38118508-91FDB71D-D7B9-4BE8-91D2-D444E038B9D2Q38123116-1547F523-33A2-4CA8-909A-8FA27148F8E9Q38123143-582ED506-8E78-4BD7-B8C5-18434282160CQ38201759-6AA607F3-D4EA-4D18-BAB4-89D9283981A0Q38851480-BAEB5F8E-B315-402D-B1F2-04F712F777AEQ48276113-166B5C28-B908-4450-AA9A-D8D6F0B308D9Q49264547-93D31D88-B20A-4535-8825-584B547714D8Q50115047-9285441E-BEAA-4EDD-AEF5-4F4AEC73DB03Q55093295-4BEFDCC3-9DFD-4D3D-AE9F-6D19509ED1E2
P2860
Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
@ast
Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
@en
type
label
Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
@ast
Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
@en
prefLabel
Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
@ast
Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
@en
P2093
P1476
Intravenous immunoglobulin does not improve outcome in toxic epidermal necrolysis.
@en
P2093
Manuel Gomez
Nicole Mittman
Robert Cartotto
Rodger Shortt
P304
P356
10.1097/01.BCR.0000124746.33279.86
P577
2004-05-01T00:00:00Z